f 2020 Recommendation column: For recommendations that were carried forward to the 2020 VA/DoD Dyslipidemia CPG, this column indicates the new corresponding recommendation(s). Recommendation Number Page 2014 Recommendation Text 2014 Strength of Recommendation Recommendation Category Recommendation We suggest that patients being considered for statin therapy be assessed for other CVD risk factors, including, but not limited to, the following: a. Age (males >35 and females >45) b. Family history of premature coronary artery disease (CAD); definite myocardial infarction (MI) or sudden death before age 55 in father or other male first-degree relative, or before age 65 in mother or other female first-degree relative c. Current tobacco use/cigarette smoking (or within the last one month) d. Hypertension (systolic blood pressure [SBP] >140 mmHg or diastolic blood pressure [DBP] >90 mmHg confirmed on more than one occasion, or current therapy with anti-hypertensive medications) e. Diabetes mellitus (DM) (See VA/DoD DM CPG, v4e.pdf). A diagnosis of DM is made if any of the following: a) Fasting plasma glucose (FPG) is 126 mg/dL on at least two occasions, or b) A single hemoglobin A1c (HbA1c) reading of 6.5%, confirmed with a FPG 126 mg/dL (these tests can be done on the same or different days); or c) HbA1c is 7% on two occasions using a clinical laboratory methodology standardized to the net splanchnic glucose production (NSGP) (not at the point of care); or d) Symptoms of hyperglycemia and a casual (random) glucose 200 mg/dL on two occasions. However, casual (random) plasma glucose is not recommended as a routine screening test. f. Level of high density lipoprotein cholesterol (HDL-C) (Less than 40 mg/dL confirmed on more than one occasion) Modified from the 2006 CPG without an updated systematic review of the evidence.